Results 1 to 10 of about 26,040 (168)

Pharmacoeconomics [PDF]

open access: yesIndian Journal of Medical and Paediatric Oncology, 2021
1Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada 2Department of Medicine, Oncology Centre, Indian Naval Hospital Ship, Asvini, Colaba, Mumbai, Maharashtra, India Address for correspondence
Mendel Suchmacher, Mauro Geller
semanticscholar   +5 more sources

Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC – Lessons from Two Continents

open access: yesFrontiers in Pharmacology, 2017
Background: Pharmacoeconomics is receiving increasing attention globally as a set of tools ensuring efficient use of resources in health systems, albeit with different applications depending on the contextual, cultural and development stages of each ...
Jacqui Miot, Michael Thiede
doaj   +2 more sources

Pharmacoeconomics [PDF]

open access: yesDefinitions, 2020
PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative and practical articles on the application of pharmacoeconomics and quality-of-life assessment to optimum drug therapy and health outcomes.
Dodel, Richard   +3 more
semanticscholar   +5 more sources

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

open access: yesNeuropsychiatric Disease and Treatment, 2013
Florian Castrop, Bernhard Haslinger, Bernhard Hemmer, Dorothea Buck Department of Neurology, Technische Universität München, Munich, Germany Abstract: Multiple sclerosis (MS) is a common neurological disease with increasing incidence and ...
Castrop F, Haslinger B, Hemmer B, Buck D
doaj   +2 more sources

The role of pharmacoeconomics in current Indian healthcare system

open access: yesJournal of Research in Pharmacy Practice, 2013
Phamacoeconomics can aid the policy makers and the healthcare providers in decision making in evaluating the affordability of and access to rational drug use.
Akram Ahmad   +5 more
doaj   +2 more sources

Pharmacoeconomics [PDF]

open access: yesMacedonian Journal of Medical Sciences, 2013
Aim: The aim of this review was to provide an overview of the terminology, technology and methodology of pharmacoeconomic evaluations. The choice is made because there is small number of reviews on this subject in Macedonia, and also because of the subject actuality.Methods: There are four common types of methods of cost-outcomes economic evaluations ...
Marc A. Darst   +2 more
  +7 more sources

Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study

open access: yesPharmacy, 2023
For the improvement of access to health, many countries including South Africa, have adopted universal healthcare. However, this requires skills to apply health technology assessments for the facilitation of investment decisions.
Carlien Schmidt   +4 more
doaj   +1 more source

Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics

open access: yesInternational Journal of Antimicrobial Agents, 2023
Nirmatrelvir/ritonavir (N/R) is one of the most effective antiviral drugs against SARS-CoV-2. The preclinical development, pharmacodynamics and pharmacokinetics of N/R are reviewed herein.
D. Focosi   +5 more
semanticscholar   +1 more source

Efficacy, safety, and pharmacoeconomics of sivelestat sodium in the treatment of septic acute respiratory distress syndrome: a retrospective cohort study.

open access: yesAnnals of Palliative Medicine, 2021
BACKGROUND Acute respiratory distress syndrome (ARDS) is one of the most organ dysfunctions in sepsis. Although the development of therapeutic strategies such as protective mechanical ventilation technology has improved the mortality of ARDS patients ...
X. Gao   +6 more
semanticscholar   +1 more source

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis

open access: yesFARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology, 2021
Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is a current problem worldwide. Currently, special attention is paid to the possibility of using new high-cost chemotherapy regimens in the treatment of MDR/XDR-
N. Nikolenko, D. Kudlay, N. Doktorova
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy